Re­call re­port: Apo­tex re­calls 2 batch­es of blood-thin­ner in­jec­tion af­ter sy­ringe mis­la­bel­ing sna­fu

Drug re­calls are an ug­ly busi­ness, par­tic­u­lar­ly be­cause they’re of­ten tied to drug­mak­ers mak­ing hard-to-miss mis­takes. In the case of Cana­di­an gener­ics mak­er Apo­tex, a la­bel­ing er­ror now has the FDA hard on its heels.

Apo­tex launched a vol­un­tary re­call of two batch­es of the blood thin­ner in­jec­tion enoxa­parin sodi­um this week af­ter dis­cov­er­ing that some sy­ringes were mis­la­beled and could’ve re­sult­ed in pa­tients ac­ci­den­tal­ly get­ting more of the drug than need­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.